Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11467-11485
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11467
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11467
Figure 16 Data from 4 studies in children with cystic fibrosis comparing 375 USP lipase units/kg/meal to higher doses for the effect on steatorrhea.
The results did not show a consistent effect on increasing the lipase dosage of an enteric coated preparation (Pancreaze®). Mean plus standard deviation are shown[79].
- Citation: Trang T, Chan J, Graham DY. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21st century. World J Gastroenterol 2014; 20(33): 11467-11485
- URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11467.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11467